Searching News Database: Imprimis Pharmaceuticals
HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
HSMN NewsFeed - 19 Oct 2017
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
HSMN NewsFeed - 23 Jun 2017
Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director
Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director
HSMN NewsFeed - 2 May 2017
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
HSMN NewsFeed - 10 Feb 2016
Imprimis Pharmaceuticals to Make a Lower Cost Compounded and Customizable Alternative to Thiola(R)
Imprimis Pharmaceuticals to Make a Lower Cost Compounded and Customizable Alternative to Thiola(R)
HSMN NewsFeed - 8 Sep 2014
Imprimis Pharmaceuticals Appoints Healthcare Leader William H. Nelson to its Board of Directors
Imprimis Pharmaceuticals Appoints Healthcare Leader William H. Nelson to its Board of Directors
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!